2022
DOI: 10.1093/nar/gkac1046
|View full text |Cite
|
Sign up to set email alerts
|

The next-generation Open Targets Platform: reimagined, redesigned, rebuilt

Abstract: The Open Targets Platform (https://platform.opentargets.org/) is an open source resource to systematically assist drug target identification and prioritisation using publicly available data. Since our last update, we have reimagined, redesigned, and rebuilt the Platform in order to streamline data integration and harmonisation, expand the ways in which users can explore the data, and improve the user experience. The gene–disease causal evidence has been enhanced and expanded to better capture disease causality… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
138
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
4
1

Relationship

2
8

Authors

Journals

citations
Cited by 201 publications
(138 citation statements)
references
References 42 publications
0
138
0
Order By: Relevance
“…5A, Table S3 ). In parallel, using the OpenTargets and Omnipath databases (24,25), we identified 834 LR pairs ( Table S4 ) associated with genetic risk for SCZ and prioritized 18 inter- and intra-cellular interactions where both counterparts showed disease association, including 9 interactions involving the protein tyrosine kinase, FYN ( Fig. 5A, Fig S40 ).…”
Section: Resultsmentioning
confidence: 99%
“…5A, Table S3 ). In parallel, using the OpenTargets and Omnipath databases (24,25), we identified 834 LR pairs ( Table S4 ) associated with genetic risk for SCZ and prioritized 18 inter- and intra-cellular interactions where both counterparts showed disease association, including 9 interactions involving the protein tyrosine kinase, FYN ( Fig. 5A, Fig S40 ).…”
Section: Resultsmentioning
confidence: 99%
“…Drug repurposing. Independent genetic signals from the cross-ancestry meta-analysis were searched in OpenTargets.org 39 for druggability and medication target status based on nearest genes. Among them, OPRM1 implicated naltrexone and GABRA4 implicated acamprosate, both current treatments for AUD.…”
Section: Transcriptome-wide Association Analyses (Twas)mentioning
confidence: 99%
“…For example, biological processes “regulation of lysosomal lumen pH” (GO:0035751) and “lysosomal lumen pH elevation” both regulate the biological attribute (trait) “lysosomal lumen pH” (OBA:0000091). OBA trait terms imported into EFO can facilitate computational drug target identification via the Open Targets Platform 60 . For example, OBA, in tandem with other ontologies, has proved useful for computational drug target identification in a study of drug-induced adverse events in animal models 61 .…”
Section: Resultsmentioning
confidence: 99%